SASMA is proud to present a fantastic line up of presenters for the 2019 SASMA Conference. Below is a profile on each of the presenters:
Dr Louise Tulloh
Louise has been practicing sport and exercise medicine for over 20 years. She values a holistic approach to patient care and works within a bio-psycho-social framework where possible, understanding that people have their own unique set of circumstances to each problem. In this way, she tailors management plans in a bespoke fashion- for the elite, the recreational, the worker and the inactive. Louise has particular interest in: Female athletes (hormonal changes, nutritional deficiency, menstrual and bone health), Fatigue in athletes (especially endurance athletes), persisting pain (knee, pelvis, back and neck), Lifestyle, stress, eating psychology and weight management.
Dr Adrian Elliott
Dr Elliott is a physiologist and research scientist with a particular interest in the role of exercise testing and interventions in patients with cardiovascular disease, , cardiac arrhythmias, heart failure and implanted devices. He also has research interests relating to cardiac adaptations and arrhythmias within endurance athletes. Dr Elliott is supported by a fellowship from the National Heart Foundation and is based in the Centre for Heart Rhythm Disorders (University of Adelaide/Royal Adelaide Hospital/South Australian Health & Medical Research Institute). Dr Elliott is an accredited exercise physiologist (ESSA).
Professor Mark Hutchinson
Mark Hutchinson is a Professor within the Adelaide Medical School and is the Director of the ARC Centre of Excellence for Nanoscale BioPhotonics. Professor Hutchinson returned to the University of Adelaide in 2009 as an NHMRC CJ Martin Research Fellow, and established the Neuroimmunopharmacology research laboratory. From 2005 to 2009 Mark worked in the world leading laboratory of Prof Linda Watkins in the Center for Neuroscience at the University of Colorado, Boulder USA. Here he pioneered with Prof Watkins the research which has led to the discovery of a novel drug activity in innate immune receptors.